The emergency declaration, which was made public Saturday, lets doctors and nurses temporarily bypass certain federal requirements so they can better handle a spike in influenza A(H1N1) patients.

The declaration comes just days after Health Secretary Kathleen Sebelius warned that demand was outstripping supply of vaccine for the novel flu strain.

"The 2009 H1N1 pandemic continues to evolve," Obama said in the declaration.

"The rates of illness continue to rise rapidly within many communities across the nation, and the potential exists for the pandemic to overburden health care resources in some localities."

US officials however said the declaration was not issued due to any specific development, but rather as a pre-emptive measure.

As Americans waited for more vaccine shipments, 46 of the 50 states now report widespread swine flu activity -- an unusually early uptick that ordinarily takes place in January or February at the peak of a normal flu season.

"By rapidly identifying the virus, implementing public health measures, providing guidance for health professionals and the general public, and developing an effective vaccine, we have taken proactive steps to reduce the impact of the pandemic and protect the health of our citizens," Obama said.

Among other things, the declaration gives Sebelius temporary authority to allow local authorities to set up makeshift emergency rooms to treat possible flu victims separate from regular patients.

In a note to Congress, Obama said the move was implemented "in order to be prepared in the event of a rapid increase in illness across the nation that may overburden health care resources."

At least 4,999 people have died from swine flu infections worldwide since April, when an outbreak was first reported in Mexico before rapidly spreading to the United States, according to the World Health Organization.

In the United States, Sebelius first declared a public health emergency in response to the virus on April 26, and renewed that declaration on July 24 and October 1.

"We are nowhere near where we thought we'd be by now," Centers for Disease Control and Prevention (CDC) chief Thomas Frieden said Friday of the amount of vaccine available.

Because of the vaccine shortage, the state of New York on Friday suspended a contentious requirement for health care workers to be inoculated against swine flu by the end of next month, or risk losing their jobs.

As of Friday, the CDC had 16.1 million doses of swine flu vaccine ready for shipping, and more than 11 million doses have been sent out to state health authorities.

But according to The New York Times, some states have requested 10 times the amount they have been allotted.

US officials predicted last spring that as many as 120 million doses could be available by now, with nearly 200 million by year's end, the paper said. But production problems plagued some of the five companies contracted to make the vaccine.

Around half of the doses available now were nasal mist, which can only be administered to healthy people between the ages of two and 49, and excludes those individuals particularly at risk of infection -- pregnant women, people with chronic respiratory illness like asthma and very young children.

earlier related report
Swine flu spreads in Europe as global toll nears 5,000
Swine flu is spreading faster and claiming new fatalities in Europe, health officials said Friday, as the global death toll from the virus rose to nearly 5,000 victims.

Since the A(H1N1) virus was uncovered in April, there have been over 4,735 deaths reported to the World Health Organisation as of a week ago, the WHO said.

Most of the fatal cases -- 3,539 -- have been recorded in North and South America, the UN health agency said in its latest update on the flu pandemic.

But with the winter flu season approaching in the northern hemisphere, swine flu deaths were reported in several European countries this week, with Dutch health officials saying the situation has reached an epidemic level.

"The spread of the A(H1N1) virus in the Netherlands accelerated this week. It is now a small epidemic," said the Dutch institute for health and the environment in a statement.

"Around 10 people infected with the virus were admitted daily to hospitals this week," it said.

A 14-year-old girl became the first otherwise healthy person to die from the virus, bringing to six the number of swine flu deaths so far in the Netherlands.

In Britain, the worst hit country in Europe, new swine flu cases nearly doubled in a week, from 27,000 to 53,000, and the number of deaths now total 128, according to updated figures released this week.

New deaths from the virus were also reported in Germany, its third fatality, and for the first time in the Czech Republic.

The Czech health ministry confirmed Friday that a 31-year-old woman who had the A(H1N1) virus, and also suffered from heart problems, was the country's first fatality linked to swine flu.

The Czech Republic is the 18th country in the European Union to report at least one death from swine flu, according to a top health official, Michael Vit.

"The situation is under control. We have been one of the countries relatively spared, but the virus is spreading around Europe and is found among the population," he added.

Many of the 27 EU member states have begun or are set to start vaccination programmes.

Greece announced Friday the first phase of its vaccination campaign will start in the middle of next month, Greece's ANA news agency reported.

The first group to be vaccinated from November 10-25 will consist of people with chronic illnesses, pregnant women, people working in hospitals and those in charge of children less than than six months old, ANA said.

British drug maker GlaxoSmithKline (GSK) said Friday that, to date, more than 150,000 people have received its vaccine, Pandemrix, as part of government initiated vaccination programmes across Europe which started last week.

The question of how many doses of the vaccine people should receive was again addressed by the European Medicines Agency (EMEA) Friday.

The EMEA's committee for medicinal products for human use reiterated recommendations from September that the three H1N1 vaccines -- Celvapan, Focetria and Pandemrix -- should be taken as two doses at least three weeks apart.

But according to the limited data available so far, one dose for Pandemrix and Focetria may be enough, it added.

Celvapan is made by US drugmaker Baxter amd Focetria by Novartis of Switzerland.

Share This Article With Planet Earth

del.icio.us	Digg	Reddit
YahooMyWeb	Google	Facebook

Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola

Memory Foam Mattress Review

SPACE MEDIA NETWORK PROMOTIONS Solar Energy Solutions Tempur-Pedic Mattress Comparison ... Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News